Independently verified UK research peptides: what 'lab tested' actually means

For research purposes only. Not for human consumption. 18+. UK only. This article describes laboratory verification methodology for the UK research community. It does not describe personal use, dosing, or therapeutic effects.

Definition

An independently verified research peptide is a compound whose purity and identity have been confirmed by an analytical laboratory that is not the manufacturer or seller, using methods documented in a Certificate of Analysis (COA) that names the testing laboratory, lists the testing methodology, and is published publicly per batch.

The four words that matter: named, methodology, per-batch, public.

Without all four, "lab tested" is marketing language, not a verifiable claim.

This article describes what each of those four properties actually requires, why each is independently necessary, and how researchers can verify a supplier's claims before purchase. It uses two analytical laboratories currently in UK research-supply use — PeptideVerify (UK independent analytical lab) and Janoshik Analytical — as worked examples. It does not name competitor suppliers.

Why this article exists

The UK research peptide supply chain is uneven. Some suppliers publish full Certificates of Analysis (COAs) per batch from named third-party laboratories. Others claim "lab tested" or "HPLC verified" without naming the laboratory, without showing a COA, or by referring to in-house testing performed by the supplier or a contracted lab the supplier will not name.

These are not equivalent claims. A claim that cannot be independently verified is not a verified claim. The research community — researchers reading published peptide literature, study-readers evaluating reproducibility, and institutional purchasers checking compliance — needs a structured way to distinguish the two.

What follows is a reference, not a sales argument. The methodology described applies to any UK supplier, including BioHack London. Where BioHack London's posture is described, it is to make the methodology concrete; the same scrutiny should be applied to every supplier the reader considers.

The four-part test

A claim of independent verification requires four properties, all of which are independently necessary. Removing any one of them breaks the claim.

1. Named laboratory

The testing laboratory must be identified by name, with a discoverable corporate or institutional identity. "Independent third-party laboratory" without a name is not a verified claim. It cannot be falsified, it cannot be cross-referenced, and it provides no accountability path.

In UK research-supply practice, two analytical laboratories appear in current use as named third-party testing providers:

  • PeptideVerify is a UK-based independent analytical laboratory specialising in HPLC purity verification and mass spectrometry identity confirmation for research peptides. Each batch tested through PeptideVerify receives a certificate ID (e.g. PV-7CB661-IHCB-26) and is logged in their public verification portal, allowing any party — supplier, customer, or third party — to confirm the certificate is authentic.
  • Janoshik Analytical is an independent third-party analytical laboratory long-established in the international research-supply network. Janoshik publishes per-batch HPLC and mass spectrometry results that are widely referenced in research-community archives. The aggregator Finnrick maintains a publicly accessible index of Janoshik's published results across multiple supplier batches, providing a cross-supplier reference dataset for researchers.

Both laboratories are named, both publish per-batch certificates, both are independently discoverable, and both have a verification path that does not depend on the trustworthiness of the supplier passing the COA along.

A supplier claim that names a laboratory the reader can independently look up is verifiable. A supplier claim that does not is not.

2. Methodology

A COA must specify how the analysis was performed. The two analytical methods the research community expects to see are HPLC and mass spectrometry.

High-Performance Liquid Chromatography (HPLC). A separation technique that resolves the components of a sample by their physical interaction with a stationary phase under a controlled mobile-phase flow. For peptide purity verification, HPLC quantifies the proportion of the target peptide in the sample relative to the total of all UV-detectable species. A reading of "≥99% purity by HPLC" means: 99% or more of the UV-detected material in the chromatogram corresponds to the target peptide; the remaining ≤1% is other species (process residues, truncated sequences, oxidation products).

HPLC purity verification has known limitations. It quantifies what is present in the chromatogram, but it does not by itself confirm that the dominant peak is the correct peptide rather than a similar-mass impurity. For that, mass spectrometry is required.

Mass spectrometry (MS). A technique that ionises a sample and measures the mass-to-charge ratio of the resulting ions. For research peptides, MS confirms that the molecular weight of the dominant peak matches the expected molecular weight of the target peptide sequence. A peptide with a theoretical mass of 1,419 Da that elutes as the dominant HPLC peak with an observed mass of 1,419 Da has been confirmed both for purity (by HPLC) and identity (by MS).

A COA that reports only HPLC purity, without mass spectrometry identity confirmation, is incomplete. A COA that reports only mass spectrometry, without HPLC purity, is also incomplete. Both methodologies appear on a complete COA because they answer different questions.

3. Per-batch

Peptide batches vary. Two batches of the same compound from the same manufacturer can differ in measured purity by 1–3 percentage points and in impurity profile substantially more. Research methodology requires that purity and identity be confirmed for the specific batch being shipped, not for an earlier batch from the same product line.

A "≥99% pure" claim that references a single COA from a previous batch and applies it to all subsequent batches is not a per-batch claim. It is a marketing summary of one historical test.

A genuine per-batch verification posture means:

  • Each batch receives its own COA
  • The COA references a specific batch number that appears on the product label
  • A purchaser can match the batch they receive to the COA they were shown
  • New batches receive new COAs; old COAs are not reused

In UK research-supply practice, this is what BioHack London publishes. Each product page on biohacklondon.com links to the active batch's COA. Each COA names the analytical lab, the methodology, the certificate ID, and the batch number. The same standard is applied to every product, regardless of price point.

4. Public

A COA that exists but is not publicly accessible — gated behind a customer login, available "on request only," or shown to authorised distributors — provides limited verification value to a researcher choosing between suppliers. The act of publishing the COA, openly and in advance of purchase, is itself a credibility signal: a supplier confident in their analytical results does not gate them.

In UK research-supply practice, full public COA disclosure means:

  • COAs accessible without account creation
  • COAs accessible without an email submission
  • COAs accessible from the product page or a dedicated verification archive
  • The verification page is discoverable from the homepage, not buried

The verification archive at biohacklondon.com/test-reports is one example of this posture. Other UK suppliers publish per-product COAs on individual product pages. Both patterns satisfy the public-disclosure criterion. What does not satisfy it: a generic "we test all our products" statement, with COAs only available "on request" or only to logged-in customers.

What 'lab tested' commonly means in practice

Marketing language across the UK research peptide supply chain uses a small set of phrases. The list below describes what each phrase typically does, and does not, signify in practice. None of these phrases is inherently dishonest — but each requires verification before being treated as a verified claim.

"HPLC verified" / "HPLC tested"

Tells the reader: the supplier claims HPLC analysis was performed. Does not tell the reader: by which laboratory, with what methodology detail, in what year, on which batch, with what result, or whether a COA can be produced on request.

"Independent third-party tested" (without named laboratory)

Tells the reader: the supplier claims someone other than the supplier performed testing. Does not tell the reader: who, with what credentials, where the certificate is, or whether the lab is genuinely independent of the supplier (a contracted in-house lab the supplier owns is not a third-party lab regardless of how it is labelled).

"Lab tested" / "Quality tested"

Tells the reader: testing was performed. Does not tell the reader: by whom, with what methodology, or whether the testing was done by the manufacturer, the supplier, an in-house lab, or an independent third party.

"Pharmaceutical-grade" / "Research-grade"

Tells the reader: the supplier asserts a quality category. Does not tell the reader: against what standard. "Pharmaceutical-grade" has no enforced legal definition for research peptides in the UK; the term has been adopted by suppliers across a wide range of actual quality.

"GMP-compliant facility" (without named facility, audit, or certification)

Tells the reader: the supplier asserts manufacturing process compliance. Does not tell the reader: by which auditor, against which GMP standard (there are several), and whether GMP applies to the manufacturing or the analytical testing or both.

"ISO 9001 lab" (without named lab)

Tells the reader: the supplier asserts the testing lab carries an ISO 9001 quality-management certification. Does not tell the reader: which lab. ISO 9001 is also a quality-management standard for processes, not an analytical-accuracy certification — relevant but not equivalent to ISO 17025, which is the analytical-accuracy standard. Without a named lab, neither claim is verifiable.

The pattern across these phrases is consistent. Each can be entirely accurate, or entirely empty, depending on whether the supplier provides the verifiable specifics. The presence of the phrase tells the reader nothing without those specifics.

How a researcher verifies a supplier's claim

The methodology below applies to any UK supplier. It is the same methodology a research procurement officer at an institutional buyer would apply.

Step 1 — Locate the COA

Before purchase, navigate to the product page and look for a COA link or a link to a verification archive. If neither is visible, navigate to the supplier's homepage and look for a /test-reports, /coa, /lab-reports, or /verification link. If no public verification page exists, the four-part test has already failed at the "public" step.

Step 2 — Identify the testing laboratory

Read the COA and find the laboratory name. If the COA does not name the laboratory — if it carries the supplier's letterhead and an unsigned testing summary, or names "third-party laboratory" without identification — the four-part test has failed at the "named" step. Stop here.

Step 3 — Cross-reference the laboratory

Search for the named laboratory independently. A genuine third-party analytical lab will have:

  • A discoverable corporate web presence
  • A published methodology and accreditation list
  • A verification portal or contact mechanism for confirming certificate authenticity

If the named lab cannot be found, or has no presence beyond a single mention on the supplier's website, the claim is unverifiable.

Step 4 — Confirm methodology coverage

Confirm the COA reports both HPLC purity and mass spectrometry identity confirmation. A COA that reports only one method has confirmed only one property. If the supplier characterises the product as "verified" while showing only HPLC, ask whether mass spectrometry is run and whether that COA can be produced.

Step 5 — Match batch number

Confirm the COA's batch number matches the batch number on the product label. If the COA shown is for a previous batch and the current batch carries no COA, the per-batch criterion has failed.

A supplier whose claims pass all five steps is operating to the four-part standard. A supplier whose claims fail at any step is making a less-verified claim than their marketing language implies. The reader is responsible for applying this scrutiny; no UK regulator does it on the reader's behalf.

Why this matters for the research community

The research community's interest in laboratory verification is not abstract. Three concrete consequences follow from the four-part test.

Reproducibility. A study, an experiment, or a research observation depends on the input materials being what they are claimed to be. If the peptide used in a research observation was 87% pure rather than 99% pure, the data may not be reproducible by another researcher using a different batch — and the variance in the result may be misattributed to biological variation when in fact it traces to material variation.

Citation traceability. A peer-reviewed paper that cites a research peptide as the input material implicitly assumes the material was characterised. A supplier whose verification posture is opaque cannot be cited in published methodology in good faith without independent characterisation by the receiving researcher.

Cost of bad data. The cost of a research observation generated from poorly-characterised material is higher than the cost of a verified material. The verified material is more expensive at the point of purchase; the unverified material is more expensive in researcher time, data discarded, and reputation downstream.

The four-part test is not a quality grade. It is the minimum methodological floor for treating any analytical claim as verified.

Frequently asked questions

Is "third-party tested" the same as "third-party verified"?

No. "Tested" describes an action; "verified" requires the test to be both independent of the seller and externally confirmable. A supplier who runs in-house testing on their own product can accurately say "tested" without satisfying "verified."

If a supplier publishes a COA but does not name the lab, is that better than no COA?

Marginally. An unsigned COA on a supplier's letterhead provides no independent accountability. It can be photoshopped or recycled across batches without external check. A COA whose laboratory cannot be cross-referenced is not a verified document.

What is the difference between PeptideVerify and Janoshik Analytical?

PeptideVerify is a UK-based independent analytical laboratory; Janoshik Analytical is an internationally-established third-party analytical laboratory long-used in the research-supply network. Both perform HPLC purity verification and mass spectrometry identity confirmation. Both publish per-batch certificates with discoverable IDs. The differences are operational rather than methodological.

Why does Janoshik appear in research-community discussions more than other named labs?

Janoshik publishes per-batch certificates that are aggregated by the publicly accessible Finnrick reference index. This means a researcher comparing batches across multiple suppliers — or verifying a single batch's history — has a single discoverable source of cross-supplier data. The community's preference reflects this transparency, not an analytical advantage.

Does naming a lab guarantee a peptide's quality?

No. Naming a lab makes the analytical claim verifiable. A verifiable claim of low purity is still a low-purity claim. The four-part test addresses verifiability, not quality. A reader confirming verification still must read the actual COA values to assess quality.

Can I rely on a UK supplier without ISO 17025 certification?

ISO 17025 is the international standard for analytical-laboratory competence. It is not a strict requirement for research-peptide verification, but it is a stronger credential than ISO 9001. Many independent analytical labs serving the research-peptide market operate to ISO 17025-aligned methodology without holding the formal certification, which is a significant cost for a small lab. The presence of named methodology, public per-batch COAs, and a discoverable laboratory identity is the practical floor.

What should I do if I have already purchased from a supplier whose COA does not name a lab?

Apply the verification methodology retroactively. Contact the supplier and ask for the laboratory name in writing. If they decline or cannot provide it, the material is unverified for your purposes; treat it accordingly in your research notes.

What to do next

For researchers orienting themselves in the UK research-peptide supply landscape:

  1. Read primary research literature for any compound under consideration before evaluating suppliers. Methodology is the foundation; supply is downstream.
  2. Apply the four-part test to every supplier you consider — including BioHack London. The methodology does not exempt any supplier.
  3. Save COAs for any batch you receive in your research records, alongside the batch number and date of purchase. Reproducibility tomorrow depends on documentation today.

Related references:

Disclaimer. This article is a methodology reference for the UK research community on evaluating analytical-verification claims by research-peptide suppliers. It does not constitute medical, legal, regulatory, or research-design advice. The compounds referenced in this article are sold and intended for in vitro laboratory research use only, not approved for human or veterinary use, not medicines, and not intended for diagnosis, treatment, cure, or prevention of any disease. The naming of analytical laboratories in this article describes UK research-supply practice as observed; it is not an endorsement, and the reader is responsible for applying their own verification standards. Where competitor suppliers are referenced through general patterns, no specific competitor is identified, and no claim is made about any specific competitor's lawfulness or quality.

Sebastian Reuters is a science and health writer working with BioHack London on research-orientation content. He covers analytical methodology, regulatory landscape, and supplier-evaluation topics for the UK research community.

About the author

Sebastian Reuters is a science and health writer working with BioHack London on research-orientation content. He covers analytical methodology, regulatory landscape, and supplier-evaluation topics for the UK research community.

Related reading